Why the study?
Do atropine and L-NAME alter cutaneous blood flow during body heating in humans?
Do atropine and L-NAME alter cutaneous blood flow during body heating in humans?
The study demonstrates that neither sweating nor nitric oxide release via muscarinic receptor activation is essential for sustaining cutaneous vasodilation during body heating in humans.
This is the authors' abstract. We don't add key points for this paper.
We sought to investigate further the roles of sweating, ACh spillover, and nitric oxide (NO) in the neurally mediated cutaneous vasodilation during body heating in humans. Six subjects were heated with a water-perfused suit while cutaneous blood flow was measured with a laser-Doppler flowmeter. After a rise in core temperature (1. 0 +/- 0.1 degrees C) and the establishment of cutaneous vasodilation, atropine and subsequently the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) were given to the forearm via a brachial artery catheter. After atropine infusion, cutaneous vascular conductance (CVC) remained constant in five of six subjects, whereas L-NAME administration blunted the rise in CVC in three of six subjects. A subsequent set of studies using intradermal microdialysis probes to selectively deliver drugs into forearm skin confirmed that atropine did not affect CVC. However, perfusion of L-NAME resulted in a significant decrease in CVC (37 +/- 4%, P < 0.05). The results indicate that neither sweating nor NO release via muscarinic receptor activation is essential to sustain cutaneous dilation during heating in humans.
Answers are grounded in this paper and cite their sources.
Questions reliance on muscarinic NO release for heat-induced cutaneous vasodilation; leaves open non-cholinergic NO sources in human thermoregulation.
No takes yet. Share an insight, caveat, or question.
Shastry et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: